The treatment resulted in a potent antitumor effect in a subcutaneous osteosarcoma (OS) model with improved long‐term immunity against tumor recurrence and enhanced dendritic cell maturation and tumor infiltration of CD8 + T lymphocytes. Here, CD8A is linked to neoplasm.